Pfizer-BioNTech vaccine could be ready for approval by mid-October -- but there are still 'unknowns'

Pfizer and BioNTech are confident they can have a vaccine against the novel coronavirus ready for regulatory approval by the middle of October or early November, BioNTech CEO and co-founder Ugur Sahin told CNN Tuesday.

Click Here to read the entire article...